Nicholas Company Inc. Grows Stock Position in Simulations Plus, Inc. $SLP

Nicholas Company Inc. boosted its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 4.8% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 183,858 shares of the technology company’s stock after buying an additional 8,420 shares during the quarter. Nicholas Company Inc.’s holdings in Simulations Plus were worth $3,208,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Simulations Plus by 4.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company’s stock valued at $233,000 after buying an additional 390 shares during the period. US Bancorp DE grew its position in Simulations Plus by 15.6% in the 1st quarter. US Bancorp DE now owns 6,576 shares of the technology company’s stock valued at $161,000 after acquiring an additional 889 shares during the last quarter. Values First Advisors Inc. increased its stake in Simulations Plus by 3.2% in the first quarter. Values First Advisors Inc. now owns 39,188 shares of the technology company’s stock worth $960,000 after purchasing an additional 1,211 shares during the period. Rhumbline Advisers increased its stake in Simulations Plus by 2.1% in the first quarter. Rhumbline Advisers now owns 66,222 shares of the technology company’s stock worth $1,624,000 after purchasing an additional 1,334 shares during the period. Finally, Cook Wealth LLC increased its stake in Simulations Plus by 12.7% in the first quarter. Cook Wealth LLC now owns 13,960 shares of the technology company’s stock worth $342,000 after purchasing an additional 1,574 shares during the period. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Simulations Plus Price Performance

Shares of SLP stock opened at $17.18 on Friday. Simulations Plus, Inc. has a 1-year low of $12.39 and a 1-year high of $37.67. The stock’s 50-day moving average is $15.44 and its 200 day moving average is $20.03. The company has a market cap of $345.78 million, a P/E ratio of -5.45 and a beta of 0.99.

Wall Street Analyst Weigh In

A number of analysts have weighed in on SLP shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Simulations Plus in a research note on Wednesday, October 8th. Cowen started coverage on Simulations Plus in a research note on Tuesday, September 30th. They issued a “hold” rating on the stock. Stephens reduced their target price on Simulations Plus from $28.00 to $20.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 15th. TD Cowen initiated coverage on Simulations Plus in a research note on Tuesday, September 30th. They issued a “hold” rating and a $16.00 target price on the stock. Finally, William Blair reissued an “outperform” rating on shares of Simulations Plus in a research report on Tuesday, July 15th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Simulations Plus presently has a consensus rating of “Hold” and an average target price of $24.40.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.